Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer-Reference-Cited by-同舟云学术

Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer

Published:2018-08 Issue:2 Volume:268 Page:215-222
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Jang Jin-Young,Han Youngmin,Lee Hongeun,Kim Sun-Whe,Kwon Wooil,Lee Kyung-Hun,Oh Do-Youn,Chie Eui Kyu,Lee Jeong Min,Heo Jin Seok,Park Joon Oh,Lim Do Hoon,Kim Seong Hyun,Park Sang Jae,Lee Woo Jin,Koh Young Hwan,Park Joon Seong,Yoon Dong Sup,Lee Ik Jae,Choi Seong Ho

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference29 articles.

1. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer;Jang;Ann Surg,2014

2. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages;Gillen;PLoS Med,2010

3. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?;Nitecki;Ann Surg,1995

4. The role of neoadjuvant therapy in pancreatic cancer: a review;Russo;Future Oncol,2016

5. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease;Katz;J Am Coll Surg,2008

Cited by 529 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally Advanced Pancreas Cancer, Is There a Role for Surgery?;Surgical Clinics of North America;2024-10

2. A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer;Surgery;2024-10

3. miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer;Annals of Surgical Oncology;2024-09-13

4. Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis;Pancreatology;2024-09

5. Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes;Practical Radiation Oncology;2024-09